191 related articles for article (PubMed ID: 32904664)
1. Practical recommendations for the safe use of gadolinium in magnetic resonance imaging: a Delphi expert panel study.
Baroni RH; Bauab T; Bittencourt LK; D'Ippolito G; Goldman SM; Hohgraefe Neto G; Manzella A; Rocha AJ; Sonoda LA; Takeda FS
Radiol Bras; 2020; 53(4):216-222. PubMed ID: 32904664
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Jabehdar Maralani P; Shabana W; Tang A; Tsampalieros A; van der Pol C; Hiremath S
Can Assoc Radiol J; 2018 May; 69(2):136-150. PubMed ID: 29706252
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists.
Costa AF; van der Pol CB; Maralani PJ; McInnes MDF; Shewchuk JR; Verma R; Hurrell C; Schieda N
Can Assoc Radiol J; 2018 Nov; 69(4):373-382. PubMed ID: 30249408
[TBL] [Abstract][Full Text] [Related]
4. Update on Gadolinium Based Contrast Agent Safety, From the
Starekova J; Pirasteh A; Reeder SB
AJR Am J Roentgenol; 2023 Oct; ():. PubMed ID: 37850581
[TBL] [Abstract][Full Text] [Related]
5. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
6. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.
Mithal LB; Patel PS; Mithal D; Palac HL; Rozenfeld MN
Pediatr Radiol; 2017 May; 47(6):657-664. PubMed ID: 28283727
[TBL] [Abstract][Full Text] [Related]
7. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.
Rudnick MR; Wahba IM; Leonberg-Yoo AK; Miskulin D; Litt HI
Am J Kidney Dis; 2021 Apr; 77(4):517-528. PubMed ID: 32861792
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families.
Noda SM; Oztek MA; Stanescu AL; Maloney E; Shaw DWW; Iyer RS
Pediatr Radiol; 2022 Feb; 52(2):345-353. PubMed ID: 33978802
[TBL] [Abstract][Full Text] [Related]
9. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium Deposition in Neurology Clinical Practice.
Smith TE; Steven A; Bagert BA
Ochsner J; 2019; 19(1):17-25. PubMed ID: 30983897
[No Abstract] [Full Text] [Related]
11. Safety issues related to intravenous contrast agent use in magnetic resonance imaging.
Ponrartana S; Moore MM; Chan SS; Victoria T; Dillman JR; Chavhan GB
Pediatr Radiol; 2021 May; 51(5):736-747. PubMed ID: 33871726
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Richter H; Fingerhut S; Martin LF; Xia A; Henze N; Paulus W; Sperling M; Karst U; Jeibmann A
Invest Radiol; 2019 Sep; 54(9):531-536. PubMed ID: 31261291
[TBL] [Abstract][Full Text] [Related]
13. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
14. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium Deposition in the Brain: Current Updates.
Choi JW; Moon WJ
Korean J Radiol; 2019 Jan; 20(1):134-147. PubMed ID: 30627029
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium Deposition: A Study Review.
Strickler SE; Clark KR
Radiol Technol; 2021 Jan; 92(3):249-258. PubMed ID: 33472877
[TBL] [Abstract][Full Text] [Related]
17. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists.
Schieda N; Maralani PJ; Hurrell C; Tsampalieros AK; Hiremath S
Can Assoc Radiol J; 2019 Aug; 70(3):226-232. PubMed ID: 31255393
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
19. GBCAs and Risk for Nephrogenic Systemic Fibrosis: A Literature Review.
Beam AS; Moore KG; Gillis SN; Ford KF; Gray T; Steinwinder AH; Graham A
Radiol Technol; 2017 Jul; 88(6):583-589. PubMed ID: 28900045
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]